Origin and relationship with other drugs
From a biochemical perspective, Isosorbidi mononitras (specifically isosorbide-5-mononitrate) is the direct and primary active metabolite of another well-known drug, isosorbide dinitrate. This continuity determines the common features of their pharmacological profile, yet this monometabolite possesses several significant advantages regarding bioavailability.
Various dosage forms are used in therapeutic practice. In addition to standard options, there are special prolonged-release formulations (e.g., Efox long and Monocinta retard) that provide a smoother and more sustained release of the active substance.
Pharmacokinetic advantages
Compared to its precursor, isosorbide dinitrate, Isosorbidi mononitras favorably differs in a set of pharmacokinetic parameters:
- High bioavailability: the drug is absorbed and enters the systemic circulation more effectively.
- Extended half-life ($t_{1/2}$): ensures a more stable concentration of the active component in the blood.
- Prolonged antianginal effect: the therapeutic action persists for 12 hours or more, which is especially pronounced when using sustained-release (prolonged) formulations.
The problem of tolerance and cross-tolerance
The main therapeutic challenge when using this drug is the phenomenon of tachyphylaxis. Like all other organic nitrates, Isosorbidi mononitras causes the development of tolerance with prolonged and continuous use, meaning a gradual decrease in the therapeutic effect.
Additionally, the drug is characterized by so-called cross-tolerance. This means that a drop in the body's sensitivity to isosorbide mononitrate automatically entails a decrease in the efficacy of other nitrate compounds, particularly nitroglycerin preparations.
Briefly: answers to topical questions
What is the mechanism of the antianginal action of isosorbide mononitrate at the cellular level?
The mechanism of action consists in the enzymatic release of nitric oxide (NO) from organic nitrates with the participation of thiol enzymes and tissue sulfhydryl groups. At the cellular level, the reaction cascade includes:
- Entry of NO into vascular smooth muscle cells (angiocytes).
- Activation of cytosolic guanylyl cyclase.
- Accumulation of cyclic guanosine monophosphate (cGMP).
- Decrease in cytosolic calcium ion concentration.
As a result, relaxation of vascular smooth muscle cells occurs.
What are the main clinical indications for prescribing isosorbide mononitrate?
The main indications include:
- Relief and prevention of angina pectoris attacks.
- Chronic heart failure — as a vasodilator when ACE inhibitors cannot be used.
Which side effects are most characteristic of isosorbide mononitrate preparations?
The most characteristic side effects include:
- Headache and flushing.
- Hypotension, including orthostatic hypotension, and syncope.
- Reflex tachycardia.
- Methemoglobinemia.
Overall, the side effects are similar to those of nitroglycerin, but may be less pronounced.
How to prevent the development of tolerance during long-term administration of isosorbide mononitrate?
To prevent the development of tolerance, the drugs must be prescribed intermittently. A nitrate-free interval must be maintained between the last dose of the drug and the first dose on the following day: at least 12 hours, optimally 16 hours. Other sources indicate an interval of 10–14 hours.
What are the absolute contraindications to taking isosorbide mononitrate?
Contraindications include:
- Vasospastic angina (Prinzmetal's angina) due to the risk of increased coronary vascular tone.
- Hypertrophic obstructive cardiomyopathy (HOCM).
- Severe aortic stenosis.
- Concomitant use of phosphodiesterase type 5 (PDE5) inhibitors due to the risk of severe arterial hypotension.
Mononitrate is "Mono" (single active metabolite) with a long duration of effect (up to 12 hours), but remember about tolerance: patients quickly develop tolerance to nitrates!
Class and exam questions
To which pharmacological group does Isosorbide mononitrate belong?
The drug belongs to the class of organic nitrates and is an active metabolite of isosorbide dinitrate (isosorbide-5-mononitrate).
What are the main pharmacokinetic advantages of the drug over dinitrate?
It has higher bioavailability and an extended half-life ($t_{1/2}$). Due to this, the antianginal effect lasts up to 12 hours and longer.
Does tachyphylaxis develop to this medication?
Yes. Like other organic nitrates, long-term use causes tolerance, and it is characterized by cross-tolerance with nitroglycerin preparations.
What else to study on this topic
- Detailed analysis of the mechanisms of tolerance development to organic nitrates
- Regimens for preventing tachyphylaxis in nitrate therapy
- Comparison of pharmacokinetic parameters between short-acting and prolonged-release formulations (Efox long, Monocinta retard)
- Clinical manifestations of cross-tolerance with nitroglycerin
- Features of the metabolism of isosorbide dinitrate into the active metabolite
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Isosorbide mononitrate" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.